Research Center Juelich GmbH, Institute of Biotechnology 2, Juelich, Germany.
Biotechnol J. 2009 Nov;4(11):1610-8. doi: 10.1002/biot.200900049.
Bovine enterokinase is a serine protease that catalyzes the hydrolysis of peptide bonds and plays a key role in mammalian metabolism. Because of its high specificity towards the amino acid sequence (Asp)(4)-Lys, enterokinase is a potential tool for the cleavage of fusion proteins, which are gaining more importance in biopharmaceutical production. A candidate for adaptive cancer immunotherapy is mucin 1, which is produced recombinantly as a fusion protein in CHO cells. Here, we present the first repetitive application of immobilized enterokinase for the cleavage of the mucin fusion protein. The immobilization enables a facile biocatalytic process due to simplified separation of the biocatalyst and the target protein. Immobilized enterokinase was applied in a maximum of 18 repetitive reactions. The enzyme utilization (total turnover number) was increased significantly 419-fold compared to unbound enzyme by both immobilization and optimization of process conditions. Slight enzyme inactivation throughout the reaction cycles was observed, but was compensated by adjusting the process time accordingly. Thus, complete fusion protein cleavage was achieved. Furthermore, we obtained isolated mucin 1 with a purity of more than 90% by applying a simple and efficient purification process. The presented results demonstrate enterokinase to be an attractive tool for fusion protein cleavage.
牛肠激酶是一种丝氨酸蛋白酶,能够催化肽键的水解,在哺乳动物代谢中起着关键作用。由于其对氨基酸序列(Asp)(4)-Lys 的高度特异性,肠激酶是切割融合蛋白的潜在工具,在生物制药生产中越来越受到重视。黏蛋白 1 是一种适应性癌症免疫治疗的候选物,它在 CHO 细胞中作为融合蛋白进行重组表达。在这里,我们首次重复应用固定化肠激酶来切割黏蛋白融合蛋白。由于生物催化剂和目标蛋白的分离简化,固定化使其能够实现简便的生物催化过程。固定化肠激酶在最多 18 次重复反应中得到了应用。与未结合的酶相比,通过固定化和优化反应条件,酶的利用率(总周转率)显著提高了 419 倍。尽管在整个反应循环中观察到了轻微的酶失活,但通过相应地调整反应时间进行了补偿。因此,实现了融合蛋白的完全切割。此外,通过应用简单有效的纯化工艺,我们获得了纯度超过 90%的分离黏蛋白 1。所呈现的结果表明肠激酶是一种有吸引力的融合蛋白切割工具。